Guardant Health, Inc. (GH) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
GH currently has 131M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 7.35% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 131.3M shares outstanding |
130M | 0 |
| Oct 29, 2025 |
10-Q filing | 124.8M shares outstanding |
120M | 0 |
| Jul 30, 2025 |
10-Q filing | 124.1M shares outstanding |
120M | 0 |
| Apr 30, 2025 |
10-Q filing | 123.9M shares outstanding |
120M | 0 |
| Feb 20, 2025 |
10-K filing | 122.7M shares outstanding |
120M | 0 |
| Nov 06, 2024 |
10-Q filing | 123.1M shares outstanding |
120M | 0 |
| Aug 07, 2024 |
10-Q filing | 122.4M shares outstanding |
120M | 0 |
| May 09, 2024 |
10-Q filing | 121.7M shares outstanding |
120M | 0 |
| Feb 22, 2024 |
10-K filing | 112.0M shares outstanding |
110M | 0 |
| Nov 06, 2023 |
10-Q filing | 117.7M shares outstanding |
120M | 0 |
| Aug 03, 2023 |
10-Q filing | 108.8M shares outstanding |
110M | 0 |
| May 09, 2023 |
10-Q filing | 102.7M shares outstanding |
100M | 0 |
| Feb 23, 2023 |
10-K filing | 102.2M shares outstanding |
100M | 0 |
| Nov 03, 2022 |
10-Q filing | 102.3M shares outstanding |
100M | 0 |
| Aug 04, 2022 |
10-Q filing | 102.0M shares outstanding |
100M | 0 |
| May 05, 2022 |
10-Q filing | 101.9M shares outstanding |
100M | 0 |
| Feb 24, 2022 |
10-K filing | 101.3M shares outstanding |
100M | 0 |
| Nov 04, 2021 |
10-Q filing | 101.4M shares outstanding |
100M | 0 |
| Aug 05, 2021 |
10-Q filing | 101.2M shares outstanding |
100M | 0 |
| May 06, 2021 |
10-Q filing | 101.1M shares outstanding |
100M | 0 |
| Feb 25, 2021 |
10-K filing | 100.4M shares outstanding |
100M | 0 |
| Nov 05, 2020 |
10-Q filing | 100.0M shares outstanding |
100M | 0 |
| Oct 13, 2020 |
8-K filing: Guardant Health, Inc. announces the completion of an underwritten public offering of 7,000,000 shares of its common stock at a price of $102.00 per share, with all shares sold by the Selling Stockholder. |
99M | 0 |
| Aug 06, 2020 |
10-Q filing | 99.4M shares outstanding |
99M | 0 |
| Jun 04, 2020 |
8-K filing: Guardant Health, Inc. entered into an underwriting agreement for a public offering of 11,500,000 shares of common stock at $84.00 per share, consisting of 3,750,000 shares issued by the Company and 7,750,000 shares sold by the Selling Stockholder, with an option for the underwriter to purchase an additional 1,725,000 shares. |
94M | 0 |
| May 07, 2020 |
10-Q filing | 94.3M shares outstanding |
94M | 0 |
| Mar 02, 2020 |
10-K filing | 85.8M shares outstanding |
86M | 0 |